<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02845635</url>
  </required_header>
  <id_info>
    <org_study_id>Pro00072319</org_study_id>
    <nct_id>NCT02845635</nct_id>
  </id_info>
  <brief_title>MS Mosaic: A Longitudinal Research Study on Multiple Sclerosis</brief_title>
  <official_title>MS Mosaic: A Longitudinal Research Study on Multiple Sclerosis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Duke University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Duke University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to better characterize the fluctuations in multiple sclerosis
      symptoms and their relationship to medications, to length/extent of disease, and to a variety
      of physiologic measures.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 29, 2017</start_date>
  <completion_date type="Anticipated">August 2025</completion_date>
  <primary_completion_date type="Anticipated">August 2025</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Change in perceived fatigue severity (self-report) as recorded by symptom diary</measure>
    <time_frame>Every 24 hours through study completion, an average of 6 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in perceived cognitive impairment (self-report) as recorded by symptom diary</measure>
    <time_frame>Every 24 hours through study completion, an average of 6 months</time_frame>
    <description>Severity of cognitive impairment experienced from multiple sclerosis</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in perceived depression or anxiety severity (self-report) as recorded by symptom diary</measure>
    <time_frame>Every 24 hours through study completion, an average of 6 months</time_frame>
    <description>Severity of any mood disorders experienced from multiple sclerosis</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in perceived walking instability (self-report) as recorded by symptom diary</measure>
    <time_frame>Every 24 hours through study completion, an average of 6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in perceived vision difficulties (self-report) as recorded by symptom diary</measure>
    <time_frame>Every 24 hours through study completion, an average of 6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in perceived Bowel/Bladder dysfunction (self-report) as recorded by symptom diary</measure>
    <time_frame>Every 24 hours through study completion, an average of 6 months</time_frame>
    <description>Severity of bowel/bladder dysfunction experienced from multiple sclerosis</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in perceived sensory disturbance (self-report) as recorded by symptom diary</measure>
    <time_frame>Every 24 hours through study completion, an average of 6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in perceived vertigo severity (self-report) as recorded by symptom diary</measure>
    <time_frame>Every 24 hours through study completion, an average of 6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in perceived dysarthria severity (self-report) as recorded by symptom diary</measure>
    <time_frame>Every 24 hours through study completion, an average of 6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in pain (self-report) as recorded by symptom diary</measure>
    <time_frame>Every 24 hours through study completion, an average of 6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in sleep quality as recorded by app-linked wearable device</measure>
    <time_frame>Every 24 hours through study completion, an average of 6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in medication adherence (self-report) as recorded by medication diary</measure>
    <time_frame>Every 24 hours through study completion, an average of 6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in self-efficacy (self-report) as determined by the Multiple Sclerosis self-efficacy scale (survey instrument)</measure>
    <time_frame>every three months, through study completion (an average of 6 months)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Multiple Sclerosis Quality of Life Inventory</measure>
    <time_frame>prompted based on the app user's responses on the daily surveys, up to 6 months</time_frame>
    <description>The Multiple Sclerosis Quality of Life Inventory surveys are prompted based on the app user's responses on the daily surveys.</description>
  </secondary_outcome>
  <number_of_groups>4</number_of_groups>
  <enrollment type="Anticipated">2000</enrollment>
  <condition>Multiple Sclerosis</condition>
  <arm_group>
    <arm_group_label>Relapsing Remitting Multiple Sclerosis</arm_group_label>
    <description>Those who document during the study on-boarding process that they suffer from relapsing-remitting multiple sclerosis.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Primary Progressive Multiple Sclerosis</arm_group_label>
    <description>This who document during the on-boarding process that they suffer from primary progressive multiple sclerosis.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Secondary Progressive Multiple Sclerosis</arm_group_label>
    <description>This who document during the on-boarding process that they suffer from secondary progressive multiple sclerosis.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <description>This who document during the on-boarding process that they do not suffer from multiple sclerosis.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Personal history of multiple sclerosis</intervention_name>
    <description>Participants will be stratified into one of four cohorts based on their experience (or lack of experience) with the three major forms of multiple sclerosis.</description>
    <arm_group_label>Relapsing Remitting Multiple Sclerosis</arm_group_label>
    <arm_group_label>Primary Progressive Multiple Sclerosis</arm_group_label>
    <arm_group_label>Secondary Progressive Multiple Sclerosis</arm_group_label>
    <arm_group_label>Control</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Study subjects will be self-selecting from the national release of a mobile application.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Be at least 18 years old

          -  Live in the United States of America

          -  Read/write in English

        Exclusion Criteria:
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Fletcher L Hartsell, MD MPH</last_name>
    <role>Principal Investigator</role>
    <affiliation>Duke University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Fletcher L Hartsell, MD MPH</last_name>
    <phone>919-684-8615</phone>
    <email>lee.hartsell@duke.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Katherine Heller, PhD</last_name>
    <phone>919-684-3437</phone>
    <email>katherine.heller@duke.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Duke University Medical Center</name>
      <address>
        <city>Durham</city>
        <state>North Carolina</state>
        <zip>27710</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Fletcher L Hartsell, MD MPH</last_name>
      <phone>919-684-8615</phone>
      <email>lee.hartsell@duke.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 14, 2016</study_first_submitted>
  <study_first_submitted_qc>July 22, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 27, 2016</study_first_posted>
  <last_update_submitted>October 2, 2017</last_update_submitted>
  <last_update_submitted_qc>October 2, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">October 4, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sclerosis</mesh_term>
    <mesh_term>Multiple Sclerosis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

